Magic Pills Online

Is Endomorphin The ‘Super Morphine’ That Will End The Need For Opioids?

Today’s vilify from dailymail.co.uk (see division below) could signal the breakthrough all neuropathy patients experiencing chronic pain hold been waiting for. It talks in regard to using ‘endomorphin’ as an alternative to morphine and other opioids but without the obliqueeffects! (There will be a come up post from another source tomorrow.) The endomorphin drugs are peptide-based, and target the same pain-relieving opioid receptor as morphine. Endomorphin is naturally produced in the body but targeted endomorphin drugs may certainly be able to replace opioids in the appearance of neuropathic pain treatments. It’s some old story but it’s but at the rat-testing stage at the consequence and will be two years before human testing begins but the potential is obvious. More information in tomorrow’s mail.

Researchers reveal ‘super morphine’ that has every part of of the painkilling properties but is NOT addictiveBy Lisa Ryan For Dailymail.com Published: 29 January 2016

A neurochemical has wholly the painkilling effects of morphine, scientists declarationEndomorphin is not addictive and has fewer indirecteffects, a study revealedAnd, endomorphin doesn’t give rise to the same respiratory depressionThis strange drug could offer pain relief destitute of risking opioid addiction

Health officials be favored with frequently warned of the opioid pandemic sweeping America.

There has been a 200 for cent increase in opioid-related deaths because 2000 – with many of those deaths occurring since of prescription painkillers, according to the Centers since Disease Control.

However, scientists may own the answer – a powerful painkiller that isn’t addictive.

Endomorphin – what one. is found naturally in the corpse – can be as strong because morphine, but with fewer sidegoods, according to a study from Tulane University.

Dr James Zadina, a professor of remedial agent, pharmacology and neuroscience, said: ‘These indirecteffects were absent or reduced through the new drug.

‘It’s unprecedented for a peptide to deliver of the like kind powerful pain relief with so small in number sideeffects.’

The study, published in the newspaper Neuropharmacology, tested several engineered variants of the neurochemical endomorphin adhering rats.

The scientists compared endomorphin to morphia – in an attempt to allot the drugs’ effectiveness and side–personal estate.

The endomorphin drugs are peptide-based, and mark the same pain-relieving opioid receptor taken in the character of morphine.

Opium-based drugs are the chiefly common treatments for severe and of long duration pain – but they can exist severely addictive.